Literature DB >> 7634666

The infected nonunion of the tibia.

C L Toh1, J B Jupiter.   

Abstract

Ununited fracture of the tibia complicated by infection is not only a complex surgical problem but also a chronic and at times debilitating condition. The principle methods used to diagnose and stage posttraumatic tibial osteomyelitis are described. Infected nonunions of the tibia are characterized by the extent of bony loss and the presence of a functional ipsilateral fibula. Using this tibial staging criteria, a series of 37 infected nonunions of the tibia are reviewed. Twenty patients were male and 16 were female, with an average age of 33 years. The distal third of the tibia was involved in 19 patients, the middle third in 11, and proximal third in 7. Twenty three of the tibia were infected with > 1 organism. Thirty were Type 3 (tibial defect of 6 cm or less with a long and usable fibula), 4 Type 4 (tibial defect > 6 cm without usable fibula), and 3 Type 5 (tibial defect > 6 cm without usable fibula). The patients were evaluated at an average of 61 months after treatment. Union and eradication of infection were achieved in 35 of 37 patients. The results of the Health Impact Analysis suggest that the infected nonunion of the tibia represented a chronic and debilitating disorder with a lasting impact.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634666

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  14 in total

1.  Ilizarov's method: a solution for infected bone loss.

Authors:  K Fabry; J Lammens; P Delhey; J Stuyck; U Z Pellenberg
Journal:  Eur J Orthop Surg Traumatol       Date:  2005-11-25

2.  Stability of tibial defect reconstruction with fibular graft and unilateral external fixation: a finite element study.

Authors:  Huiqiang Chen; Ying Zhang; Hong Xia; Fei Wang; Zhibo Li; Xuxiang Chen
Journal:  Int J Clin Exp Med       Date:  2014-01-15

3.  Indolent infection in nonunion of the distal femur.

Authors:  Ji Wan Kim; Seong-Eun Byun; Hyoung Keun Oh; Jung Jae Kim
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-09-05

4.  Ilizarov methodology for infected non union of the Tibia: Classic circular transfixion wire assembly vs. hybrid assembly.

Authors:  Ranjit Kr Baruah
Journal:  Indian J Orthop       Date:  2007-07       Impact factor: 1.251

5.  Free vascularised fibular grafting in the treatment of large skeletal defects due to osteomyelitis.

Authors:  Yuan Sun; Changqing Zhang; Dongxu Jin; Jiagen Sheng; Xiangguo Cheng; Xudong Liu; Shengbao Chen; Bingfang Zeng
Journal:  Int Orthop       Date:  2009-03-24       Impact factor: 3.075

6.  Metaphyseal locking compression plate as an external fixator for the distal tibia.

Authors:  Sven A F Tulner; Simon D Strackee; Peter Kloen
Journal:  Int Orthop       Date:  2012-06-01       Impact factor: 3.075

7.  Surgical site infection in high-energy peri-articular tibia fractures with intra-wound vancomycin powder: a retrospective pilot study.

Authors:  Keerat Singh; Jennifer M Bauer; Gregory Y LaChaud; Jesse E Bible; Hassan R Mir
Journal:  J Orthop Traumatol       Date:  2015-05-10

8.  Combined use of Ilizarov external fixation and Papineau technique for septic pseudoarthrosis of the distal tibia in a patient with diabetes mellitus.

Authors:  Stefanos D Koutsostathis; Panagiotis Lepetsos; Vasilios D Polyzois; Spyros G Pneumaticos; George A Macheras
Journal:  Diabet Foot Ankle       Date:  2014-02-12

9.  Use of antibiotic cement-impregnated intramedullary nail in treatment of infected non-union of long bones.

Authors:  Ashok K Shyam; Parag K Sancheti; Salim K Patel; Steve Rocha; Chetan Pradhan; Atul Patil
Journal:  Indian J Orthop       Date:  2009-10       Impact factor: 1.251

10.  Comparison of Clinico-radiological Outcomes of Monolateral Fixator in Infected Non-union of Tibia Based on Bone Gap Quantification.

Authors:  Jitendra Wadhwani; Rajesh Rohilla; Ramchander Siwach; Roop Singh; Ashish Devgan; Sumedha Vashishth
Journal:  Indian J Orthop       Date:  2020-03-02       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.